These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 34266726

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [Abstract] [Full Text] [Related]

  • 4. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models.
    Li R, Yin H, Wang J, He D, Yan Q, Lu L.
    Clin Rheumatol; 2021 Oct; 40(10):4269-4277. PubMed ID: 34013490
    [Abstract] [Full Text] [Related]

  • 5. Antifibrotic Effects of Hepatocyte Growth Factor on Endothelial-to-Mesenchymal Transition via Transforming Growth Factor-Beta1 (TGF-β1)/Smad and Akt/mTOR/P70S6K Signaling Pathways.
    Wang Z, Fei S, Suo C, Han Z, Tao J, Xu Z, Zhao C, Tan R, Gu M.
    Ann Transplant; 2018 Jan 02; 23():1-10. PubMed ID: 29292365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity.
    Liang M, Lv J, Chu H, Wang J, Chen X, Zhu X, Xue Y, Guan M, Zou H.
    J Dermatol Sci; 2014 Nov 02; 76(2):104-11. PubMed ID: 25258031
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autophagy mediates 2-methoxyestradiol-inhibited scleroderma collagen synthesis and endothelial-to-mesenchymal transition induced by hypoxia.
    Liu C, Zhou X, Lu J, Zhu L, Li M.
    Rheumatology (Oxford); 2019 Nov 01; 58(11):1966-1975. PubMed ID: 31049569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E, Privitera D, Bodio C, Lonati PA, Borghi MO, Ingegnoli F, Meroni PL, Chighizola CB.
    Arthritis Res Ther; 2020 Nov 09; 22(1):265. PubMed ID: 33168071
    [Abstract] [Full Text] [Related]

  • 13. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
    Nakai K, Karita S, Igarashi J, Tsukamoto I, Hirano K, Kubota Y.
    J Dermatol Sci; 2019 Apr 09; 94(1):205-212. PubMed ID: 30954335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Failed degradation of JunB contributes to overproduction of type I collagen and development of dermal fibrosis in patients with systemic sclerosis.
    Ponticos M, Papaioannou I, Xu S, Holmes AM, Khan K, Denton CP, Bou-Gharios G, Abraham DJ.
    Arthritis Rheumatol; 2015 Jan 09; 67(1):243-53. PubMed ID: 25303440
    [Abstract] [Full Text] [Related]

  • 17. Bone morphogenetic protein-7 inhibits endothelial-mesenchymal transition in pulmonary artery endothelial cell under hypoxia.
    Zhang H, Liu Y, Yan L, Du W, Zhang X, Zhang M, Chen H, Zhang Y, Zhou J, Sun H, Zhu D.
    J Cell Physiol; 2018 May 09; 233(5):4077-4090. PubMed ID: 28926108
    [Abstract] [Full Text] [Related]

  • 18. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
    Kasamatsu H, Chino T, Hasegawa T, Utsunomiya N, Utsunomiya A, Yamada M, Oyama N, Hasegawa M.
    Arthritis Res Ther; 2023 Aug 25; 25(1):156. PubMed ID: 37626391
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
    Kim KM, Heo DR, Lee J, Park JS, Baek MG, Yi JM, Kim H, Bang OS.
    Chem Biol Interact; 2015 Jan 05; 225():32-9. PubMed ID: 25446852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.